Article
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Antimicrobial agents and chemotherapy - 1 Jan 2012
Tashiro Masato, Izumikawa Koichi, Minematsu Asuka, Hirano Katsuji, Iwanaga Naoki, Ide Shotaro, Mihara Tomo, Hosogaya Naoki, Takazono Takahiro, Morinaga Yoshitomo, Nakamura Shigeki, Kurihara Shintaro, Imamura Yoshifumi, Miyazaki Taiga, Nishino Tomoya, Tsukamoto Misuzu, Kakeya Hiroshi, Yamamoto Yoshihiro, Yanagihara Katsunori, Yasuoka Akira, Tashiro Takayoshi, Kohno Shigeru
Abstract excerpt
We investigated the triazole, amphotericin B, and micafungin susceptibilities of 196 A. fumigatus clinical isolates in Nagasaki, Japan. The percentages of non-wild-type (non-WT) isolates for which MICs of itraconazole, posaconazole, and voriconazole were above the ECV were 7.1%, 2.6%, and 4.1%, respectively. A G54 mutation in cyp51A was detected in 64.2% (9/14 isolates) and 100% (5/5 isolates) of non-WT isolates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
